These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18308406)

  • 21. Atovaquone and ELQ-300 Combination Therapy as a Novel Dual-Site Cytochrome bc1 Inhibition Strategy for Malaria.
    Stickles AM; Smilkstein MJ; Morrisey JM; Li Y; Forquer IP; Kelly JX; Pou S; Winter RW; Nilsen A; Vaidya AB; Riscoe MK
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4853-9. PubMed ID: 27270285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial electron transport inhibition and viability of intraerythrocytic Plasmodium falciparum.
    Painter HJ; Morrisey JM; Vaidya AB
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5281-7. PubMed ID: 20855748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First case of emergence of atovaquone-proguanil resistance in Plasmodium falciparum during treatment in a traveler in Comoros.
    Savini H; Bogreau H; Bertaux L; Bouchiba H; Kraemer P; Parzy D; Garnotel E; Rogier C; Simon F; Pradines B
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2283-4. PubMed ID: 18411319
    [No Abstract]   [Full Text] [Related]  

  • 24. Exploration of 4(1H)-pyridones as a novel family of potent antimalarial inhibitors of the plasmodial cytochrome bc1.
    Bueno JM; Herreros E; Angulo-Barturen I; Ferrer S; Fiandor JM; Gamo FJ; Gargallo-Viola D; Derimanov G
    Future Med Chem; 2012 Dec; 4(18):2311-23. PubMed ID: 23234553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different mutation patterns of atovaquone resistance to Plasmodium falciparum in vitro and in vivo: rapid detection of codon 268 polymorphisms in the cytochrome b as potential in vivo resistance marker.
    Schwöbel B; Alifrangis M; Salanti A; Jelinek T
    Malar J; 2003 Mar; 2():5. PubMed ID: 12665429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations.
    Musset L; Bouchaud O; Matheron S; Massias L; Le Bras J
    Microbes Infect; 2006 Sep; 8(11):2599-604. PubMed ID: 16962361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alternative oxidase inhibitors potentiate the activity of atovaquone against Plasmodium falciparum.
    Murphy AD; Lang-Unnasch N
    Antimicrob Agents Chemother; 1999 Mar; 43(3):651-4. PubMed ID: 10049282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro efficiency of new acridyl derivatives against Plasmodium falciparum.
    Guetzoyan L; Ramiandrasoa F; Dorizon H; Desprez C; Bridoux A; Rogier C; Pradines B; Perrée-Fauvet M
    Bioorg Med Chem; 2007 May; 15(9):3278-89. PubMed ID: 17339112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the mitochondrial electron transport chain of Plasmodium falciparum: new strategies towards the development of improved antimalarials for the elimination era.
    Nixon GL; Pidathala C; Shone AE; Antoine T; Fisher N; O'Neill PM; Ward SA; Biagini GA
    Future Med Chem; 2013 Sep; 5(13):1573-91. PubMed ID: 24024949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding the mechanism of atovaquone drug resistance in Plasmodium falciparum cytochrome b mutation Y268S using computational methods.
    Akhoon BA; Singh KP; Varshney M; Gupta SK; Shukla Y; Gupta SK
    PLoS One; 2014; 9(10):e110041. PubMed ID: 25334024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming rhinacanthin analogues from potent anticancer agents into potent antimalarial agents.
    Kongkathip N; Pradidphol N; Hasitapan K; Grigg R; Kao WC; Hunte C; Fisher N; Warman AJ; Biagini GA; Kongsaeree P; Chuawong P; Kongkathip B
    J Med Chem; 2010 Feb; 53(3):1211-21. PubMed ID: 20067272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variation among Plasmodium falciparum strains in their reliance on mitochondrial electron transport chain function.
    Ke H; Morrisey JM; Ganesan SM; Painter HJ; Mather MW; Vaidya AB
    Eukaryot Cell; 2011 Aug; 10(8):1053-61. PubMed ID: 21685321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3-Halo Chloroquine Derivatives Overcome Plasmodium falciparum Chloroquine Resistance Transporter-Mediated Drug Resistance in P. falciparum.
    Edaye S; Tazoo D; Bohle DS; Georges E
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7891-3. PubMed ID: 26438496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of cytochrome bc1 as a strategy for single-dose, multi-stage antimalarial therapy.
    Stickles AM; Ting LM; Morrisey JM; Li Y; Mather MW; Meermeier E; Pershing AM; Forquer IP; Miley GP; Pou S; Winter RW; Hinrichs DJ; Kelly JX; Kim K; Vaidya AB; Riscoe MK; Nilsen A
    Am J Trop Med Hyg; 2015 Jun; 92(6):1195-201. PubMed ID: 25918204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Menoctone Resistance in Malaria Parasites Is Conferred by M133I Mutations in Cytochrome
    Blake LD; Johnson ME; Siegel SV; McQueen A; Iyamu ID; Shaikh AK; Shultis MW; Manetsch R; Kyle DE
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antimalarial activities of methylene blue and the 1,4-naphthoquinone 3-[4-(trifluoromethyl)benzyl]-menadione are not due to inhibition of the mitochondrial electron transport chain.
    Ehrhardt K; Davioud-Charvet E; Ke H; Vaidya AB; Lanzer M; Deponte M
    Antimicrob Agents Chemother; 2013 May; 57(5):2114-20. PubMed ID: 23439633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4'-chlorophenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone (566C80).
    Fry M; Pudney M
    Biochem Pharmacol; 1992 Apr; 43(7):1545-53. PubMed ID: 1314606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcript level responses of Plasmodium falciparum to antimycin A.
    Tarr SJ; Nisbet RE; Howe CJ
    Protist; 2012 Sep; 163(5):755-66. PubMed ID: 22503086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro atovaquone/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand.
    Khositnithikul R; Tan-Ariya P; Mungthin M
    Malar J; 2008 Jan; 7():23. PubMed ID: 18226262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical studies of membrane bound Plasmodium falciparum mitochondrial L-malate:quinone oxidoreductase, a potential drug target.
    Hartuti ED; Inaoka DK; Komatsuya K; Miyazaki Y; Miller RJ; Xinying W; Sadikin M; Prabandari EE; Waluyo D; Kuroda M; Amalia E; Matsuo Y; Nugroho NB; Saimoto H; Pramisandi A; Watanabe YI; Mori M; Shiomi K; Balogun EO; Shiba T; Harada S; Nozaki T; Kita K
    Biochim Biophys Acta Bioenerg; 2018 Mar; 1859(3):191-200. PubMed ID: 29269266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.